ABSTRACT
Lipoxygenases (LOXs) form a heterogeneous family of lipid-peroxidizing enzymes, and several LOX-isoforms (12/15-LOX, 5-LOX) have been implicated in atherogenesis. However, the precise role of these enzymes is still a matter of discussion. 12/15-LOXs are capable of oxidizing lipoproteins (low-density lipoprotein (LDL), high-density lipoprotein (HDL)) to atherogenic forms, and functional inactivation of this enzyme in murine atherosclerosis models slows down lesion formation. In contrast, rabbits that overexpress this enzyme were protected from lesion formation when fed a lipid-rich diet. To contribute to this discussion, we recently investigated the impact of 12/15-LOX overexpression on in vitro foam cell formation. When 12/15-LOX-transfected J774 cells were incubated in culture with modified LDL, we found that intracellular lipid deposition was reduced in the transfected cells when compared with the corresponding control transfectants. This paper briefly summarizes the current status of knowledge on the biological activity of different LOX-isoforms in atherogenesis and will also provide novel experimental data characterizing the role of 12/15-LOX in cellular LDL modification and for in vitro foam cell formation.
Subject(s)
Atherosclerosis/enzymology , Isoenzymes/physiology , Lipoxygenase/physiology , Animals , Arachidonate 12-Lipoxygenase/chemistry , Arachidonate 12-Lipoxygenase/genetics , Arachidonate 12-Lipoxygenase/physiology , Arachidonate 15-Lipoxygenase/chemistry , Arachidonate 15-Lipoxygenase/genetics , Arachidonate 15-Lipoxygenase/physiology , Arachidonate 5-Lipoxygenase , Atherosclerosis/etiology , Foam Cells/physiology , Gene Expression , Humans , Isoenzymes/chemistry , Lipoproteins, HDL/metabolism , Lipoproteins, LDL/metabolism , Lipoxygenase/chemistry , Mice , Models, Molecular , Oxidation-Reduction , Oxidative Stress , Rabbits , TransfectionABSTRACT
OBJECTIVE: Lipoxygenases with different positional specificity have been implicated in atherogenesis, but the precise roles of the various isoforms remain unclear. Because of its capability of oxidizing low-density lipoprotein (LDL) to an atherogenic form, 12/15-lipoxygenases have been suggested to initiate LDL oxidation in vivo; thus, these enzymes may exhibit pro-atherogenic activities. However, in several rabbit atherosclerosis models, the enzyme appears to act atheroprotective. METHODS AND RESULTS: To test the impact of 12/15-lipoxygenase expression on early atherogenesis, we established an in vitro foam cell model, which is based on the uptake of acetylated LDL by murine macrophages. In this system, we found that 12/15-lipoxygenase expression protects the cells from intracellular lipid deposition. This effect was related to an attenuated uptake of modified LDL, as indicated by impaired expression of scavenger receptor A and to accelerated intracellular lipid metabolism. CONCLUSIONS: Our results indicate that the role of 12/15-lipoxygenase in atherogenesis may not be restricted to oxidative LDL modification. Expression of this lipid-peroxidizing enzyme may impact both lipid uptake and intracellular lipid turnover. These data provide a plausible explanation for the antiatherogenic effect of 12/15-LOX in rabbit atherosclerosis models.